Created at	Source	Raw Value	Validated value
Feb. 25, 2022, noon	oms	To evaluate the safety of MRG-001 in Severe and Critical SARS CoV-2 patientsTimepoint: From Baseline to Day 60 or discharge	To evaluate the safety of MRG-001 in Severe and Critical SARS CoV-2 patientsTimepoint: From Baseline to Day 60 or discharge